March 2009 Volume 5, Issue 3
Volume 5, Issue 3 | March 2009
March 2009
In this Issue
Global News
Galapagos patents high-stakes Alzheimer's breakthrough
Study finds GPR3 a promising drug target for the diseaseThe Danish are coming!
Lundbeck establishes U.S. footprint with $900 million purchase of Ovation PharmaceuticalsGSK expands global footprint
GlaxoSmithKline agrees to pay E515 million to UCB for expansion into emerging marketsBehind the iron curtain
PPD acquires AbCRO, strengthens foothold in Eastern EuropePutting a little English on it
Oxford Expression Technologies signs co-marketing agreement with fellow UK company Eden BiodesignWill third time be the charm for Astellas?
Twice rejected by CV Therapeutics, Astellas takes $1.1 billion bid to shareholdersRoche-Genentech deal goes hostile
Roche takes $42B offer to Genentech\'s shareholdersResearch & Development
Merck acquires Insmed for $130 million
Deal will allow Merck to pursue follow-on biologicsSanofi-aventis outlines R&D changes, eyes acquisitions
Reporting a nearly 14 percent profit in the fourth quarter of 2008, Sanofi-aventis outlines several new initiatives aimed at growing its R&D divisionTrimming the fat
Zafgen, Argenta sign anti-obesity drug development dealSpurred into action
Philanthropist funds new AIDS institute aimed at finding HIV vaccine within a decadeCholesterol clog-buster
UT Southwestern scientists uncover compound that frees trapped cholesterolLifetree expands its branches
In an effort to expand its services to the broader arena of central nervous system-related disorders, Lifetree Clinical Research is primed to debut its Lifetree Center for Neuroscience Research.Bypassing HIV’s ‘decoy zone’
IAVI and Algonomics to collaborate on HIV protein design projectGenomics & Proteomics
The unusual suspect
Duke and Johns Hopkins researchers discover genetic link to malignant glioma that could lead to better treatment for central nervous system cancersBack to school
Mirna Therapeutics announces back-to-back oncology collaboration deals with M.D. Anderson and UCSFShooting from the HIP
Cure DM edging closer to a therapy for reversing diabetes, using a novel peptideBuying across the pond
California-based Gen-Probe plans to acquire Tepnel in the UK for $132 million and possibly tap into pharmacogenomics marketA vision for the future
Deal with Fovea helps Dyax expand reach of lead therapeutic protein candidate DX-88 into ophthalmologyInformatics
More bang for their buck
Cornell researchers partner with Ocarina Networks for cost-efficient data compression and storageImproved informatics infrastructure
USC wins $22.2 million grant for national informatics clearinghouseElectronic lab notebook for vaccine trials
Immunovirology Division of French Atomic Energy Agency selects IDBS’ BioBook to manage its research dataPhysicochemical software connection
ACD/Labs and Pharma Algorithms join forces to strengthen in silico screening and predictionOn-demand storage system
New LIMS from Sciformatix uses Software as a Service paradigm to simplify system, cut costsAutomation & Instrumentation
Back Jack, do it again
Three-year collaboration between TTP Labtech and AZ yields custom screening solution—and an order for a second unitSupercritical success
Building on a years-long relationship and a recent equity investment, Waters acquires SFC specialist Thar InstrumentsGoing with the flow
Millipore acquires Guava Technologies to further strengthen its position in the flow cytometry market
